Kineret given within 6 hrs improves outcome in ischemic stroke Dr. Kamal Kant Kohli Kohli6 April 2018 8:00 PM ISTStroke is one of the most common causes of disability in adults and a leading cause of death worldwide and it occurs when poor blood flow to the brain...
Ustekinumab Reduces Crohn's Disease Related Hospitalization and Surgery Vinay Singh singh5 Jun 2018 8:10 PM ISTTreatment with Stelara (ustekinumab) lowered the risk of Crohn's disease-related hospitalization, surgery, and the need for alternative biologic...
Methotrexate ineffective in maintaining steroid-free remission in Ulcerative Colitis Vinay Singh singh23 July 2018 7:25 PM ISTMethotrexate was not found more effective than placebo in maintaining steroid-free response or remission in ulcerative colitis, according to the...
Tanezumab Novel drug for improving pain in Osteoarthritis Vinay Singh singh23 July 2018 8:28 PM ISTA 16-week Phase 3 study (A4091056) in patients with osteoarthritis (OA) pain evaluating the subcutaneous administration of tanezumab, an...
Methotrexate Effective in Subcutaneous Psoriasis Vinay Singh singh17 Sept 2018 7:20 PM ISTA new study published in the British Journal of Dermatology has found methotrexate to be effective and superior to placebo in patients with...
New once-monthly injection approved for Migraine Prevention Dr. Kamal Kant Kohli Kohli30 Sept 2018 8:10 PM ISTGood news for patients of Migraine -A new once-monthly injection has been approved for Migraine Prevention.The Food and Drug Administration (FDA) has...
Single dose Testosterone auto-injector approved for replacement therapy Dr. Kamal Kant Kohli Kohli4 Oct 2018 7:25 PM ISTThe U.S. Food and Drug Administration has approved subcutaneous testosterone enanthate for once-weekly, at-home self-administration with an...
Once a month injectable available for schizophrenia Dr. Kamal Kant Kohli Kohli20 Nov 2018 7:28 PM ISTRisperidone long-acting once-month subcutaneous (SC) injectable, is now available for the treatment of schizophrenia. FDA had approved long-acting...
Denosumab superior to bisphosphonates in osteoporosis Vinay Singh singh16 Dec 2018 7:20 PM ISTA new study published in JCEM has reported that denosumab effectively increased bone mass in patients with low bone mineral density(BMD) or...
Subcutaneous vedolizumab also effective for ulcerative colitis treatment: VISIBLE 1 trial Medha Baranwal Baranwal5 Nov 2019 7:10 PM ISTA subcutaneous (SC) formulation of vedolizumab could be beneficial for patients with moderate to severe ulcerative colitis (UC), a recent study...
